Clinical Trials
10 trialsNCT03034304 2025-07-24
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
HRYZ Biotech Co.
Phase 1 Terminated
NCT01505569 2024-02-26
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT03628131 2018-09-19
Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
Samsung Medical Center
Phase 1/2 Unknown
NCT00623077 2017-12-05
MT2004-30: Tomotherapy for Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated
NCT00695032 2014-11-05
Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
Institut Claudius Regaud
Phase NA Suspended
NCT00003597 2014-07-24
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT00003198 2013-06-27
Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00086970 2013-01-24
Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00502892 2012-08-01
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed